Effectiveness of a web-based screening and brief intervention with weekly text-message-initiated individualised prompts for reducing risky alcohol use among teenagers: study protocol of a randomised controlled trial within the ProHEAD consortium.
Adolescence
Binge drinking
Booster
ProHEAD
Text-message intervention
Web-based intervention
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
22 Jan 2019
22 Jan 2019
Historique:
received:
02
07
2018
accepted:
22
12
2018
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
29
5
2019
Statut:
epublish
Résumé
Early and excessive alcohol use is a significant threat to healthy development. Evidence supports the effectiveness of electronic alcohol interventions for young drinkers. However, effects are typically small and studies targeting under 18-year-olds are scarce. This trial is the first to evaluate the effectiveness of a single-session, brief, motivational, web-based intervention (ProWISE) plus weekly text-message-initiated individualised prompts (TIPs) in reducing alcohol consumption and alcohol-related harm among children and adolescents aged ≥ 12 years. TIPs are designed to decrease risky alcohol use by reaching youth in the contexts of their everyday lives and by providing individualised feedback on drinking intentions, actual drinking and succession in achieving personal goals for low-risk drinking or abstinence. The trial is part of the multicentre consortium ProHEAD testing e-interventions for mental health problems in children and adolescents. Participants in grades 6-13 aged ≥ 12 years will be recruited in schools which participate in ProHEAD (target N = 15,000). Main criterion for inclusion in the ProWISE-TIP trial is a positive screening for at-risk alcohol use in the CRAFFT-d questionnaire (target n = 1076). In a multicentre, four-arm, randomised controlled design the following groups will be compared: (A) web-based intervention plus TIPs for 12 weeks; (B) web-based intervention plus text-message-initiated assessment of alcohol consumption for 12 weeks; (C) web-based intervention only; and (D) alcohol-related psychoeducation. TIPs will be delivered shortly before and after high-risk situations for excessive alcohol use and will be tailored to age, gender, drinking motives and alcohol consumption. Study participants will be followed up at three, six and nine months in the ProWISE-TIP trial and at one and two years in the ProHEAD consortium. Primary outcome is alcohol use in the past 30 days at nine months after enrolment. Secondary outcomes are alcohol-related problems, co-occurring substance use, health service utilisation, mental health problems and quality of life. Trial results will generate important evidence on how to enhance effectiveness of single-session, web-based alcohol interventions for youth. The ProWISE-TIP intervention, if effective, can be used as a stand-alone alcohol intervention or as an add-on to school-based or community-based alcohol prevention programs. German Clinical Trials Register, DRKS00014606 Registered on 20 April 2018.
Sections du résumé
BACKGROUND
BACKGROUND
Early and excessive alcohol use is a significant threat to healthy development. Evidence supports the effectiveness of electronic alcohol interventions for young drinkers. However, effects are typically small and studies targeting under 18-year-olds are scarce. This trial is the first to evaluate the effectiveness of a single-session, brief, motivational, web-based intervention (ProWISE) plus weekly text-message-initiated individualised prompts (TIPs) in reducing alcohol consumption and alcohol-related harm among children and adolescents aged ≥ 12 years. TIPs are designed to decrease risky alcohol use by reaching youth in the contexts of their everyday lives and by providing individualised feedback on drinking intentions, actual drinking and succession in achieving personal goals for low-risk drinking or abstinence.
METHODS/DESIGN
METHODS
The trial is part of the multicentre consortium ProHEAD testing e-interventions for mental health problems in children and adolescents. Participants in grades 6-13 aged ≥ 12 years will be recruited in schools which participate in ProHEAD (target N = 15,000). Main criterion for inclusion in the ProWISE-TIP trial is a positive screening for at-risk alcohol use in the CRAFFT-d questionnaire (target n = 1076). In a multicentre, four-arm, randomised controlled design the following groups will be compared: (A) web-based intervention plus TIPs for 12 weeks; (B) web-based intervention plus text-message-initiated assessment of alcohol consumption for 12 weeks; (C) web-based intervention only; and (D) alcohol-related psychoeducation. TIPs will be delivered shortly before and after high-risk situations for excessive alcohol use and will be tailored to age, gender, drinking motives and alcohol consumption. Study participants will be followed up at three, six and nine months in the ProWISE-TIP trial and at one and two years in the ProHEAD consortium. Primary outcome is alcohol use in the past 30 days at nine months after enrolment. Secondary outcomes are alcohol-related problems, co-occurring substance use, health service utilisation, mental health problems and quality of life.
DISCUSSION
CONCLUSIONS
Trial results will generate important evidence on how to enhance effectiveness of single-session, web-based alcohol interventions for youth. The ProWISE-TIP intervention, if effective, can be used as a stand-alone alcohol intervention or as an add-on to school-based or community-based alcohol prevention programs.
TRIAL REGISTRATION
BACKGROUND
German Clinical Trials Register, DRKS00014606 Registered on 20 April 2018.
Identifiants
pubmed: 30670102
doi: 10.1186/s13063-018-3160-z
pii: 10.1186/s13063-018-3160-z
pmc: PMC6341631
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
73Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GL1744D
Investigateurs
Michael Kaess
(M)
Stephanie Bauer
(S)
Rainer Thomasius
(R)
Christine Rummel-Kluge
(C)
Heike Eschenbeck
(H)
Hans-Joachim Salize
(HJ)
Katja Becker
(K)
Katja Bertsch
(K)
Sally Bilic
(S)
Romuald Brunner
(R)
Johannes Feldhege
(J)
Christina Gallinat
(C)
Sabine C Herpertz
(SC)
Julian Koenig
(J)
Sophia Lustig
(S)
Markus Moessner
(M)
Fikret Özer
(F)
Peter Parzer
(P)
Franz Resch
(F)
Sabrina Ritter
(S)
Jens Spinner
(J)
Silke Diestelkamp
(S)
Kristina Wille
(K)
Sabrina Baldofski
(S)
Elisabeth Kohls
(E)
Lina-Jolien Peter
(LJ)
Vera Gillé
(V)
Hanna Hofmann
(H)
Laya Lehner
(L)
Elke Voss
(E)
Jens Pfeiffer
(J)
Alisa Samel
(A)
Références
PLoS One. 2015 Nov 18;10(11):e0142877
pubmed: 26580802
Prev Sci. 2015 Feb;16(2):181-8
pubmed: 24930386
Trials. 2019 Jan 18;20(1):64
pubmed: 30658675
J Public Health (Oxf). 2019 Sep 30;41(3):543-549
pubmed: 30239858
J Adolesc Health. 2000 Jul;27(1):43-8
pubmed: 10867351
J Med Internet Res. 2010 Dec 19;12(5):e62
pubmed: 21169175
Eur Addict Res. 2013;19(3):121-7
pubmed: 23183686
J Clin Child Adolesc Psychol. 2009 Nov;38(6):899-908
pubmed: 20183672
PLoS One. 2011;6(10):e23748
pubmed: 21998626
Alcohol Res. 2014;36(1):9-18
pubmed: 26258996
Pediatrics. 2016 Jul;138(1):
pubmed: 27325634
Lancet. 2007 Apr 21;369(9570):1391-1401
pubmed: 17448826
Neurosci Biobehav Rev. 2016 Sep;68:880-890
pubmed: 27453570
Trials. 2019 Jan 15;20(1):53
pubmed: 30646944
Dev Psychobiol. 2010 Apr;52(3):216-24
pubmed: 20213754
Patient Educ Couns. 2016 Jan;99(1):17-35
pubmed: 26298219
J Epidemiol Community Health. 2007 Oct;61(10):902-7
pubmed: 17873228
Z Kinder Jugendpsychiatr Psychother. 2016;44(4):295-303; quiz 304-5
pubmed: 27434689
Alcohol Clin Exp Res. 2005 Mar;29(3):317-25
pubmed: 15770105
Med 2 0. 2012 Aug 14;1(2):e3
pubmed: 25075231
Prev Med Rep. 2015 Dec 24;3:83-9
pubmed: 26844193
Trials. 2019 Jan 31;20(1):94
pubmed: 30704534
Addict Behav. 2008 Sep;33(9):1249-53
pubmed: 18547738
BMC Public Health. 2012 Sep 26;12:826
pubmed: 23013141
J Consult Clin Psychol. 1983 Jun;51(3):390-5
pubmed: 6863699
Soc Sci Med. 1994 Aug;39(4):563-72
pubmed: 7973856
J Med Internet Res. 2016 Jan 08;18(1):e6
pubmed: 26747176
PLoS One. 2014 Jun 17;9(6):e99912
pubmed: 24937483
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):400-403
pubmed: 19242383
J Med Internet Res. 2012 Nov 14;14(6):e152
pubmed: 23151820
Addict Behav. 2005 Feb;30(2):389-95
pubmed: 15621412
Alcohol Alcohol. 2014 Mar-Apr;49(2):207-12
pubmed: 24232178
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Qual Life Res. 2010 Dec;19(10):1487-500
pubmed: 20668950
J Med Internet Res. 2016 May 24;18(5):e103
pubmed: 27220276
Addiction. 2009 Nov;104(11):1807-19
pubmed: 19744139
Soc Sci Med. 2013 Nov;97:161-9
pubmed: 24161101
Trials. 2019 Jan 30;20(1):91
pubmed: 30700318
Eur Child Adolesc Psychiatry. 2014 Jul;23(7):611-20
pubmed: 24248753
J Pediatr Psychol. 1997 Aug;22(4):513-31
pubmed: 9302849
Z Kinder Jugendpsychiatr Psychother. 2009 Sep;37(5):451-9
pubmed: 19739063
Minerva Pediatr. 2004 Jun;56(3):291-309
pubmed: 15252378
J Med Internet Res. 2009 May 14;11(2):e16
pubmed: 19632970
Ann Intern Med. 2015 Aug 4;163(3):205-14
pubmed: 26237752
Pediatrics. 2007 Jan;119(1):76-85
pubmed: 17200273
Br J Psychiatry. 2010 Aug;197(2):122-7
pubmed: 20679264
Psychiatry Res. 2016 Jun 30;240:272-277
pubmed: 27138817
Front Psychol. 2010 Sep 30;1:144
pubmed: 21833213
Addict Behav. 2007 Nov;32(11):2469-94
pubmed: 17590277
Addict Behav. 2004 Jan;29(1):221-3
pubmed: 14667433